Cointime

Celator Pharmaceuticals

company

About

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

  • 1 - 10

Highlights

Total Funding Amount
$15M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$15M
Industries
Biopharma,Biotechnology,Health Care,Health Diagnostics,Medical,Pharmaceutical
Founded date
Jan 1, 1999
Number Of Employee
1 - 10
Operating Status
Active

Celator Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies to treat cancer. The company focuses on CombiPlex, a drug ratio technology platform that enables to the development of combination therapies. Its products include CPX-1 (Irinotecan HCI-Floxuridine), a treatment for colorectal cancer; and CPX-351 (Cytarabine-Daunorubicin), a treatment for acute myeloid leukemia (AML). Celator Pharmaceuticals, Inc. was formerly known as Celator Technologies, Inc. The company was founded in 2000 and is headquartered in Princeton, New Jersey.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$15M
Celator Pharmaceuticals has raised a total of $15M in funding over 2 rounds. Their latest funding was raised on Jun 26, 2014 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 26, 2014 Debt Financing $15M 1 Hercules Capital — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Celator Pharmaceuticals is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing
Cointime
Content
Company